CVS deal for Signify seen facing tough antitrust review
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| CVS Caremark Corp. (NYSE: CVS) | Delayed: 94.48 +1.69 (1.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.79 | 52 Week High | $106.67 | |||
| Open | $93.08 | 52 Week Low | $69.30 | |||
| Day High | $94.84 | P/E | 25.19 | |||
| Day Low | $92.49 | EPS | $3.75 | |||
| Volume | 7,156,792 | |||||
| (NYSE: SGFY) | Delayed: 30.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.49 | 52 Week High | $ | |||
| Open | $12.02 | 52 Week Low | $ | |||
| Day High | $30.49 | P/E | N/A | |||
| Day Low | $30.49 | EPS | $ | |||
| Volume | 108,043 | |||||
